Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HER-2 Positive Malignant Carcinoma of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00614978
What this trial is testing

Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer

Who this might be right for
Metastatic Breast CancerBrain MetastasesHER2 Positive
Jules Bordet Institute 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04550494
What this trial is testing

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Castration-Resistant Prostate Carcinoma+28 more
National Cancer Institute (NCI) 29
Early research (Phase 1)Study completedNCT04509596
What this trial is testing

DZD1516 in Combination With Trastuzumab and Capecitabine, or in Combination With T-DM1, in Patients With Metastatic HER2 Positive Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Dizal Pharmaceuticals 23
Large-scale testing (Phase 3)Looking for participantsNCT06958627
What this trial is testing

The Impact of Intelligent Patient Management Model on Medication Adherence of Pyrotinib Compared to Traditional Patient Management Model: a Prospective, Multicenter, Randomized Controlled Clinical Study

Who this might be right for
HER2 Positive Breast CancerPyrotinib Treatment
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 964
Large-scale testing (Phase 3)UnknownNCT00486668
What this trial is testing

AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer

Who this might be right for
Invasive Breast Cancer
NSABP Foundation Inc 529
Testing effectiveness (Phase 2)Study completedNCT01009918
What this trial is testing

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab

Who this might be right for
Breast CancerCardiac Toxicity
University of South Florida 468
Testing effectiveness (Phase 2)Looking for participantsNCT05982678
What this trial is testing

Basket Study for Oligo-metastatic Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
The Netherlands Cancer Institute 72
Not applicableStudy completedNCT00896376
What this trial is testing

Trastuzumab in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Centre Antoine Lacassagne 49
Testing effectiveness (Phase 2)Study completedNCT00194779
What this trial is testing

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

Who this might be right for
Estrogen Receptor-negative Breast CancerEstrogen Receptor-positive Breast CancerHER2-positive Breast Cancer+6 more
University of Washington 50
Large-scale testing (Phase 3)Looking for participantsNCT06830889
What this trial is testing

BL-M07D1 Versus T-DM1 in the Adjuvant Treatment of HER2-positive Breast Cancer With Residual Invasive Cancer After Neoadjuvant Therapy

Who this might be right for
HER2-positive Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 1,450
Testing effectiveness (Phase 2)Study completedNCT01008150
What this trial is testing

Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 141
Testing effectiveness (Phase 2)Study completedNCT00788333
What this trial is testing

Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer

Who this might be right for
Breast Cancer
Bristol-Myers Squibb 40
Early research (Phase 1)Study completedNCT03364348
What this trial is testing

4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer

Who this might be right for
HER2 Positive Breast CarcinomaRecurrent Breast CarcinomaStage III Breast Cancer+4 more
George W. Sledge Jr. 18
Testing effectiveness (Phase 2)UnknownNCT03144947
What this trial is testing

Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Trastuzumab in HER2+ Breast Cancer Patients

Who this might be right for
Cancer, Breast
Gruppo Oncologico Italiano di Ricerca Clinica 65
Not applicableStudy completedNCT01777958
What this trial is testing

HELENA Study: An Observational Study of Perjeta (Pertuzumab) in First-Line Treatment in Patients With Her2-Positive Advanced Breast Cancer After Adjuvant Herceptin Therapy

Who this might be right for
Breast Cancer
Hoffmann-La Roche 135
Not applicableUnknownNCT05444647
What this trial is testing

Gut Microbiome Components Predict Response to Neoadjuvant Therapy in HER2-positive Breast Cancer Patients : A Prospective Study

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07578116
What this trial is testing

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic HER2-Positive Breast CarcinomaOligometastatic Breast Carcinoma
SWOG Cancer Research Network 562
Not applicableStudy completedNCT05412459
What this trial is testing

99mTc-DARPinG3-based HER2 Expression Molecular Imaging in HER2-positive Breast Cancer During Chemo+Targeted Therapy

Who this might be right for
HER2-positive Breast CancerFemale
Tomsk National Research Medical Center of the Russian Academy of Sciences 15
Not applicableApproved For MarketingNCT04395508
What this trial is testing

An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic

Who this might be right for
HER2-positive Breast Cancer
Genentech, Inc.
Testing effectiveness (Phase 2)Study completedNCT01142778
What this trial is testing

Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 152
Next Page